Anti-MARCO mAbs similarly induced TAM re-education towards a pro-inflammatory phenotype in preclinical mouse models of breast and colon carcinoma and melanoma, resulting in increased tumor immunogenicity and tumor growth/metastasis inhibition, and improving the efficacy of checkpoint immunotherapy [123]. Here, MARCO is linked to neoplasm.